Clinical and Experimental Hypertension This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
Thrombospondin 2 is a novel biomarker of essential hypertension and associated with nocturnal Na < sup > + < /sup > excretion and insulin resistance
CONCLUSION: Our study suggests for the first time that the circulating levels of TSP2 may be a novel potential biomarker for essential hypertension. The association between TSP2 and blood pressure may be, at least in part, related to the regulation of renal Na+ excretion, insulin resistance, and/or endothelial function.PMID:37943619 | DOI:10.1080/10641963.2023.2276029 (Source: Clinical and Experimental Hypertension)
Source: Clinical and Experimental Hypertension - November 9, 2023 Category: Cardiology Authors: Xiaoxin Zhou Longlong Zhang Xiaoqian Lin Xi Chen Hong Liu Xiaoli Yuan Qiuxia Zhao Weiwei Wang Xun Lei Pedro A Jose Chunyan Deng Jian Yang Source Type: research
Thrombospondin 2 is a novel biomarker of essential hypertension and associated with nocturnal Na < sup > + < /sup > excretion and insulin resistance
CONCLUSION: Our study suggests for the first time that the circulating levels of TSP2 may be a novel potential biomarker for essential hypertension. The association between TSP2 and blood pressure may be, at least in part, related to the regulation of renal Na+ excretion, insulin resistance, and/or endothelial function.PMID:37943619 | DOI:10.1080/10641963.2023.2276029 (Source: Clinical and Experimental Hypertension)
Source: Clinical and Experimental Hypertension - November 9, 2023 Category: Cardiology Authors: Xiaoxin Zhou Longlong Zhang Xiaoqian Lin Xi Chen Hong Liu Xiaoli Yuan Qiuxia Zhao Weiwei Wang Xun Lei Pedro A Jose Chunyan Deng Jian Yang Source Type: research
Thrombospondin 2 is a novel biomarker of essential hypertension and associated with nocturnal Na < sup > + < /sup > excretion and insulin resistance
CONCLUSION: Our study suggests for the first time that the circulating levels of TSP2 may be a novel potential biomarker for essential hypertension. The association between TSP2 and blood pressure may be, at least in part, related to the regulation of renal Na+ excretion, insulin resistance, and/or endothelial function.PMID:37943619 | DOI:10.1080/10641963.2023.2276029 (Source: Clinical and Experimental Hypertension)
Source: Clinical and Experimental Hypertension - November 9, 2023 Category: Cardiology Authors: Xiaoxin Zhou Longlong Zhang Xiaoqian Lin Xi Chen Hong Liu Xiaoli Yuan Qiuxia Zhao Weiwei Wang Xun Lei Pedro A Jose Chunyan Deng Jian Yang Source Type: research
Calcitriol reverses age-related hypertension via downregulating renal AP1/AT < sub > 1 < /sub > R pathway through regulating mitochondrial function
CONCLUSIONS: Our findings indicated that calcitriol reversed age-related hypertension via downregulating renal AP1/AT1R pathway through regulating mitochondrial function. Thus, calcitriol may be a valuable therapeutic strategy for age-related hypertension.PMID:37939250 | DOI:10.1080/10641963.2023.2277653 (Source: Clinical and Experimental Hypertension)
Source: Clinical and Experimental Hypertension - November 8, 2023 Category: Cardiology Authors: Ruifang Hua Baixiong Liu Wenxiu He Huilin Zhang Yong Liu Qiang Xie Linjun Zhou Fang Pei Source Type: research
Calcitriol reverses age-related hypertension via downregulating renal AP1/AT < sub > 1 < /sub > R pathway through regulating mitochondrial function
CONCLUSIONS: Our findings indicated that calcitriol reversed age-related hypertension via downregulating renal AP1/AT1R pathway through regulating mitochondrial function. Thus, calcitriol may be a valuable therapeutic strategy for age-related hypertension.PMID:37939250 | DOI:10.1080/10641963.2023.2277653 (Source: Clinical and Experimental Hypertension)
Source: Clinical and Experimental Hypertension - November 8, 2023 Category: Cardiology Authors: Ruifang Hua Baixiong Liu Wenxiu He Huilin Zhang Yong Liu Qiang Xie Linjun Zhou Fang Pei Source Type: research
TyG index is a predictor of all-cause mortality during the long-term follow-up in middle-aged and elderly with hypertension
CONCLUSIONS: The TyG index exhibited an L-shaped association with the risk of all-cause mortality among middle-aged and elderly with hypertension.PMID:37902269 | DOI:10.1080/10641963.2023.2272581 (Source: Clinical and Experimental Hypertension)
Source: Clinical and Experimental Hypertension - October 30, 2023 Category: Cardiology Authors: Jie Pang Linyan Qian Xiaoru Che Ping Lv Qiang Xu Source Type: research
TyG index is a predictor of all-cause mortality during the long-term follow-up in middle-aged and elderly with hypertension
CONCLUSIONS: The TyG index exhibited an L-shaped association with the risk of all-cause mortality among middle-aged and elderly with hypertension.PMID:37902269 | DOI:10.1080/10641963.2023.2272581 (Source: Clinical and Experimental Hypertension)
Source: Clinical and Experimental Hypertension - October 30, 2023 Category: Cardiology Authors: Jie Pang Linyan Qian Xiaoru Che Ping Lv Qiang Xu Source Type: research
TyG index is a predictor of all-cause mortality during the long-term follow-up in middle-aged and elderly with hypertension
CONCLUSIONS: The TyG index exhibited an L-shaped association with the risk of all-cause mortality among middle-aged and elderly with hypertension.PMID:37902269 | DOI:10.1080/10641963.2023.2272581 (Source: Clinical and Experimental Hypertension)
Source: Clinical and Experimental Hypertension - October 30, 2023 Category: Cardiology Authors: Jie Pang Linyan Qian Xiaoru Che Ping Lv Qiang Xu Source Type: research
TyG index is a predictor of all-cause mortality during the long-term follow-up in middle-aged and elderly with hypertension
CONCLUSIONS: The TyG index exhibited an L-shaped association with the risk of all-cause mortality among middle-aged and elderly with hypertension.PMID:37902269 | DOI:10.1080/10641963.2023.2272581 (Source: Clinical and Experimental Hypertension)
Source: Clinical and Experimental Hypertension - October 30, 2023 Category: Cardiology Authors: Jie Pang Linyan Qian Xiaoru Che Ping Lv Qiang Xu Source Type: research
TyG index is a predictor of all-cause mortality during the long-term follow-up in middle-aged and elderly with hypertension
CONCLUSIONS: The TyG index exhibited an L-shaped association with the risk of all-cause mortality among middle-aged and elderly with hypertension.PMID:37902269 | DOI:10.1080/10641963.2023.2272581 (Source: Clinical and Experimental Hypertension)
Source: Clinical and Experimental Hypertension - October 30, 2023 Category: Cardiology Authors: Jie Pang Linyan Qian Xiaoru Che Ping Lv Qiang Xu Source Type: research
TyG index is a predictor of all-cause mortality during the long-term follow-up in middle-aged and elderly with hypertension
CONCLUSIONS: The TyG index exhibited an L-shaped association with the risk of all-cause mortality among middle-aged and elderly with hypertension.PMID:37902269 | DOI:10.1080/10641963.2023.2272581 (Source: Clinical and Experimental Hypertension)
Source: Clinical and Experimental Hypertension - October 30, 2023 Category: Cardiology Authors: Jie Pang Linyan Qian Xiaoru Che Ping Lv Qiang Xu Source Type: research
TyG index is a predictor of all-cause mortality during the long-term follow-up in middle-aged and elderly with hypertension
CONCLUSIONS: The TyG index exhibited an L-shaped association with the risk of all-cause mortality among middle-aged and elderly with hypertension.PMID:37902269 | DOI:10.1080/10641963.2023.2272581 (Source: Clinical and Experimental Hypertension)
Source: Clinical and Experimental Hypertension - October 30, 2023 Category: Cardiology Authors: Jie Pang Linyan Qian Xiaoru Che Ping Lv Qiang Xu Source Type: research
CDN1163 alleviates SERCA2 dysfunction-induced pulmonary vascular remodeling by inhibiting the phenotypic transition of pulmonary artery smooth muscle cells
CONCLUSIONS AND IMPLICATIONS: SERCA2 dysfunction promotes PASMC phenotypic transition and pulmonary vascular remodeling by multiple mechanisms, which could be improved by SERCA2 agonist CDN1163.PMID:37899350 | DOI:10.1080/10641963.2023.2272062 (Source: Clinical and Experimental Hypertension)
Source: Clinical and Experimental Hypertension - October 29, 2023 Category: Cardiology Authors: Weimin Yu Qian Zhang Yixiang Qiu Hui Chen Xiaoyang Huang Li Xiao Gang Xu Siqi Li Pingping Hu Xiaoyong Tong Source Type: research
CDN1163 alleviates SERCA2 dysfunction-induced pulmonary vascular remodeling by inhibiting the phenotypic transition of pulmonary artery smooth muscle cells
CONCLUSIONS AND IMPLICATIONS: SERCA2 dysfunction promotes PASMC phenotypic transition and pulmonary vascular remodeling by multiple mechanisms, which could be improved by SERCA2 agonist CDN1163.PMID:37899350 | DOI:10.1080/10641963.2023.2272062 (Source: Clinical and Experimental Hypertension)
Source: Clinical and Experimental Hypertension - October 29, 2023 Category: Cardiology Authors: Weimin Yu Qian Zhang Yixiang Qiu Hui Chen Xiaoyang Huang Li Xiao Gang Xu Siqi Li Pingping Hu Xiaoyong Tong Source Type: research
RGS10 inhibits proliferation and migration of pulmonary arterial smooth muscle cell in pulmonary hypertension via AKT/mTORC1 signaling
Conclusion: Our findings reveal the modulatory role of RGS10 in PASMC and PH via AKT/mTORC1 axis. Therefore, targeting RGS10 may serve as a novel potent method for the prevention against PH."PMID:37879890 | DOI:10.1080/10641963.2023.2271186 (Source: Clinical and Experimental Hypertension)
Source: Clinical and Experimental Hypertension - October 25, 2023 Category: Cardiology Authors: Sheng Hu Yijie Zhang Chenming Qiu Ying Li Source Type: research